What Changed Since Our Last Report

The situation has escalated rapidly over the past 48 hours. Case counts have risen, the geographic scope has widened, and tensions between the U.S. and Congo's government are mounting.

As of May 22, the CDC reported 744 suspected cases, 83 confirmed cases, and 176 suspected deaths across the Democratic Republic of Congo and Uganda. This represents an increase from earlier counts. The WHO declared the outbreak a public health emergency of international concern on May 17. On May 22, it upgraded the national risk level inside Congo to 'very high,' according to the Economic Times.

A confirmed case has now appeared in Sud-Kivu Province, according to recent reports. Previously, confirmed cases were limited to Ituri and Nord-Kivu provinces. The outbreak is spreading geographically rather than remaining contained.

The U.S. Response Expands

The initial screening policy routed travelers from DRC, Uganda, and South Sudan exclusively to Washington Dulles International Airport. This has since expanded. According to NPR, two additional airports — Hartsfield-Jackson Atlanta and George Bush Intercontinental in Houston — are being activated for Ebola screening in the coming days.

The CDC confirmed this action under a Title 42 Order invoking Sections 362 and 365 of the Public Health Service Act. The order is effective for 30 days from May 18, treating the outbreak as a border-security health issue alongside broader travel precautions.

The order gives CDC authority to prevent introduction of Ebola Bundibugyo virus into the U.S. by controlling entry from affected countries. It applies to U.S. citizens and lawful permanent residents. Anyone who has been in DRC, Uganda, or South Sudan within the last 21 days faces rerouting and screening.

Still ZERO U.S. Cases

The CDC confirmed as of May 22: no Ebola cases linked to this outbreak have been confirmed in the United States. The American healthcare worker who tested positive on May 17 is being treated in Germany. That patient's high-risk contacts have been moved to Germany and the Czech Republic.

Germany was selected because of its specialized biocontainment facilities and prior experience treating Ebola patients.

Congo's Government Is Pushing Back

According to the New York Times, Congo's health officials are publicly criticizing the U.S. travel restrictions. They argue the measures stigmatize the country and may discourage people from reporting symptoms or seeking treatment — a concern rooted in experience from the 2014 West Africa outbreak.

Meanwhile, according to the same reporting, residents in Kinshasa are still crowding markets, bars, and public transportation despite international alarm. This reflects the core transmission-risk problem: airport screening at Dulles catches symptomatic travelers, but not people in the incubation window. The critical factor remains behavior change on the ground in Kinshasa, and that has not occurred.

What Mainstream Media Is Getting Wrong

Left-leaning outlets have devoted significant space to Congo officials' complaints about the U.S. travel ban, framing it as an overreaction. This is a legitimate angle, though it frequently downplays the geographic spread of the outbreak and the WHO's own risk assessment.

The reporting gap: the Bundibugyo strain itself. This is not the same Zaire strain that drove the 2014 epidemic. There is no approved vaccine for Bundibugyo, according to NPR. The treatments developed after 2014 were largely targeted at Zaire. This gap deserves far more prominence.

Another omission: coverage frequently describes this as a remote-area outbreak. Sud-Kivu Province is not remote. It borders Rwanda, Burundi, and Tanzania. The outbreak is expanding toward some of Central Africa's most densely populated border crossings.

Current Risk Assessment

The risk to people in the U.S. is currently low, per CDC analysis. No cases have emerged domestically, and screening measures are in place.

However, low risk does not mean zero risk. The outbreak's trajectory is worsening: expanding provinces, rising case counts, no vaccine for this strain, and a major city showing no behavioral changes. The U.S. government is implementing appropriate procedural measures. Their effectiveness depends entirely on developments on the ground in Congo over the next two to three weeks.

The numbers to watch: Sud-Kivu cases. Any acceleration there would significantly change the assessment.